Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients

AIDS

Volumn 12, Issue 8, 1998, Pages 895-904

  Nguyen, Bach Yen ^a,g   Clerici, Mario ^a,h   Venzon, David J ^b   Bauza, Sergio ^c,k   Murphy, William J ^d   Longo, Dan L ^e,i   Baseler, Michael ^d   Gesundheit, Neil ^f,j   Broder, Samuel ^b,k   Shearer, Gene ^a   Yarchoan, Robert ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d SAIC FREDERICK INC   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f GENENTECH INC   (United States)

^g MERCK RESEARCH LABORATORIES   (United States)

^h Dipartimento di Immunologia   (Italy)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

^j Menlo Park and VIVUS   (United States)

^k IVAX Corporation   (United States)

more..

Author keywords

Cellular immunity; Growth hormone; Immune reconstitution; Immunotherapy; Insulin like growth factor; T cell subset; Therapy; Wasting

Indexed keywords

CD4 ANTIGEN; HUMAN GROWTH HORMONE; IMMUNOGLOBULIN; INTERLEUKIN 2; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MYALGIA; NATURAL KILLER CELL; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION; WEIGHT GAIN;

EID: 7144251180     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199808000-00012     Document Type: Article

References (45)

1. Lamberts SW, Vak NK, Binnerts A: The use of growth hormone in adults: a changing scene. Clin Endocrinol 1992, 37:111-115.
2. Wilson DM: Clinical actions of growth hormone. Endocrinol Metab Clin North Am 1992, 21:519-537.
3. Krentz AJ, Koster FT, Crist DM, et al.: Anthropometric, metabolic, and immunologic effects of recombinant human growth hormone in AIDS and AIDS-related complex. J Acquir Immune Defic Syndr 1993, 6:245-251.
4. Lieberman SA, Butterfield CE, Harrison D, Hoffman AR: Anabolic effects of recombinant insulin-like growth factor-1 in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1994, 78:404-410.
5. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M: Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993, 77:956-962.
6. Schambelan M, Mulligan K, Grunfeld C, et al.: Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Ann Intern Med 1996, 125:873-882.
7. Waters D, Danska J, Hardy K, et al.: Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996, 125:865-872.
8. Fabris N, Pierpaoli W, Sorkin E: Hormones and the immunological capacity. III. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse. Clin Exp Immunol 1971, 9:209-225.
9. 3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci USA 1986, 83:5663-5667.
10. Davila DR, Brief S, Simon J, Hammer RE, Brinster RL, Kelley KW: Role of growth hormone in regulating T-dependent immune events in aged, nude, and transgenic rodents. J Neurosci Res 1987, 18:108-116.
11. Binz K, Joller P, Froesch P, Binz H, Zapf J, Froesch ER: Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor 1. Proc Natl Acad Sci USA 1990, 87:3690-3694.
12. Geffner ME, Bersch N, Lippe BM, Rosenfeld RG, Hintz RL, Golde DW: Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-1. J Clin Endocrinol Metab 1990, 71:464-469.
13. Clark R, Strasser J, McCabe S, Robbins K, Jardieu P: Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest 1993, 92:540-548.
14. Timsit J, Savino W, Safieh B, et al.: Growth hormone and insulin-like growth factor-1 stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 1992, 75:183-188.
15. Murphy WJ, Durum SK, Anver MR, Longo DL: Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J Immunol 1992, 148:3799-3805.
16. Murphy WJ, Durum SK, Longo DL: Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. J Immunol 1992, 149:3851-3857.
17. Murphy WJ, Durum SK, Longo DL: Differential effects of growth hormone and prolactin on murine T cell development and function. J Exp Med 1993, 178:231-236.
18. Murphy WJ, Durum SK, Longo DL: Human growth hormone promotes engraft ment of murine or human T cells in severe combined immunodeficient mice. Proc Natl Acad Sci USA 1992, 89:4481-4485.
19. Yarchoan R, Mitsuya H, Broder S: Challenges in the therapy of HIV infection, Immunol Today 1993, 14:303-309.
20. Schnittman SM, Denning SM, Greenhouse JJ, et al.: Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCRαβ+ and TCRγδ+ to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. Proc Natl Acad Sci USA 1990, 87:7727-7731.
21. De Rossi A, Calabro ML, Panozzo M, et al.: In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res Hum Retroviruses 1990, 6:287-298.
22. Stanley SK, McCune JM, Kaneshima H, et al.: Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993, 178:1151-1163.
23. Joshi W, Oleske JM: Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children. A study of four cases and a review of the literature. Arch Pathol Lab Med 1985, 109:142-146.
24. Schuurman HJ, Krone WJ, Broekhuizen R, et al.: The thymus in acquired immunodeficiency syndrome. Comparison with other types of immunodeficiency diseases, and presence of components of human immunodeficiency virus type 1. ,Am J Pathol 1989, 134:1329-1338.
25. Papiernik M, Brossard Y, Mulliez N, et al.: Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics 1992, 89:297-301.
26. Davis AE Jr: The histopathological changes in the thymus gland in the acquired immunodeficiency syndrome. Ann NY Acad Sci 1984, 437:493-502.
27. C enters for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36 (suppl 1S):1S-15S.
28. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR: Enhancement of the anabolic effects of growth hormone and insulin-like growth factor 1 by use of both agents simultaneously. J Clin Invest 1993, 91:391-396.
29. Laurence J, Grimison B, Gonenne A: Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro. Blood 1991, 79:467-472
30. Cancer Therapy Evaluation Program: Investigator's Handbook. Bethesda: National Cancer Institute, US Department of Health and Human Services; 1993:191.
31. Lieberman SA, Bukar J, Chen SA, et al.: Effects of recombinant human insulin-like growth factor-1 (rhIGF-1) on total and free IGF-1 concentrations, IGF-binding proteins, and glycemic response in humans. J Clin Endocrinol Metab 1992, 75:30-36.
32. Clerici M, Stocks NI, Zajac RA, et al.: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989, 84:1892-1899.
33. Clerici M, Stocks NI, Zajac RA, et al.: Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989, 339:383-385.
34. Muluk SC, Clerici M, Via CS, Weir MR, Kimmel PL, Shearer GM: Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant patients. Transplantation 1991, 52:284-191.
35. Pross HF, Baines MT, Rubin P, Shragge P, Patterson MS: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1981, 1:51-63.
36. Nguyen BY, Landucci DL, Cunnion RE, Yarchoan R, Walker RE: A case of hyperdynamic shock caused by trimethoprim-sulfamethoxazole in which no tumor necrosis factor or features of anaphylaxis were detected. Clin Infect Dis 1993, 17:885-887.
37. Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler GJ: The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 1992, 75:762-767.
38. Dahn MS, Lange MP, Jacobs LA: Insulin-like growth factor 1 production is inhibited in human sepsis. Arch Surg 1988, 123:1409-1414.
39. Clemmons DR: Role of insulin-like growth factor-1 in reversing catabolism. J Clin Endocrinol Metdb 1992, 75:1183-1185.
40. Murphy WJ, Durum SK, Anver M, Frazier M, Longo DL: Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma. Brain Behdv Immun 1992, 6:355-364.
41. Beschorner WE, Divic J, Pulido H, Yao X, Kenworthy P, Bruce G: Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor-1. Transplantation 1991, 52:879-884.
42. Mackall CL, Fleisher TA, Brown MR, et al.: Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995, 332:143-149.
43. Autran B, Carcelain G, Li TS, et al.: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
44. Hirschfeld S, Tudor-Williams G, Stocker V, et al.: Effects of recombinant human growth hormone and recombinant insulin-like growth factor-1 administration in children with human immunodeficiency virus infection and growth failure. Second National Conference on Human Retroviruses and Related Infections. Washington DC, January-February 1995 [abstract 511].
45. Sharma UK, Song H, Casella SJ, Schwartz DH: Failure of insulin-like growth factor 1 to suppress HIV type 1 in adult or umbilical cord mononuclear cells. AIDS Res Hum Retroviruses 1997, 13:105-110.